Biosimilars Market Will Grow at Highest Pace Owing to Rising Demand for Cost-Effective Drugs
Biosimilars are biopharmaceutical drugs that are molecularly similar with equivalent therapeutic efficacy and safety as compared to corresponding reference biologics. Biosimilars provide a cost-effective alternate to expensive biologics and expand patient access. With patent expiry of large molecular biologics, biosimilars offer significant cost savings and enable more patients to access...
0 Commentarios 0 Acciones 612 Views 0 Vista previa